This week’s data for 12- to 17-year-olds show:
- 4,740 total adverse events, including 117 rated as serious and four reported deaths among 12 to 17-year-olds. The youngest deaths reported include two 15-year-olds (VAERS I.D. 1187918 and 1242573), a 16-year-old (VAERS I.D. 1225942) and one 17-year-old (VAERS I.D. 1199455). There were other reported deaths in children under 17 that could not be confirmed or contained obvious errors.
- 635 reports of anaphylaxis among 12- to17-year-olds with 97% of cases attributed to Pfizer’s vaccine, 2% to Moderna and 0.31% (or two cases) to J&J.
- 40 reports of myocarditis and pericarditis (heart inflammation) all attributed to Pfizer’s COVID vaccine.
- 16 reports of blood clotting disorders, all attributed to Pfizer.